{
  "ticker": "LLY",
  "analysis_asof": "2026-04-17T19:13:15.005919+09:00",
  "market_data_asof": "2026-04-16",
  "level_basis": "daily_close",
  "thesis_state": "constructive",
  "primary_setup": "watch_only",
  "portfolio_stance": "BULLISH",
  "entry_action_base": "WAIT",
  "setup_quality": "DEVELOPING",
  "confidence": 0.68,
  "action_if_triggered": "NONE",
  "starter_fraction_of_target": null,
  "breakout_level": null,
  "breakout_confirmation": "close_above",
  "pullback_buy_zone": null,
  "invalid_if_close_below": null,
  "invalid_if_intraday_below": null,
  "min_relative_volume": 1.0,
  "session_vwap_preference": "indifferent",
  "event_guard": {
    "earnings_date": null,
    "block_new_position_within_days": 0,
    "allow_add_only_after_event": false,
    "requires_post_event_rerun": false
  },
  "reason_codes": [
    "trigger:923-925_위_일봉_종가_회복과_최근_평균을_웃도는_거래량",
    "trigger:923-925_회복_후_해당_구간을_지지로_재확인",
    "trigger:rsi_50_회복_및_macd가_0선_방향으로_개선",
    "trigger:939-955_위_종가로_단기_반등_모멘텀_강화_확인",
    "trigger:976-979_위_종가로_중기_추세_복구_신호_확인",
    "trigger:902-903_아래_종가_또는_888_하향_압력_발생_시_하방_경고",
    "trigger:foundayo_승인_신청,_fda_시판_후_연구_범위,_라벨_문구_관련_업데이트",
    "trigger:다음_실적에서_자유현금흐름,_capex,_재고,_매출채권,_공급능력_가이던스_확인"
  ],
  "notes": [
    "catalyst:foundayo의_심혈관_및_사망률_개선_데이터와_간_안전성_신호_부재가_당뇨·비만_프랜차이즈_확장_기대를_",
    "catalyst:2형_당뇨_적응증에_대한_q2_말까지의_미국_승인_신청_계획",
    "catalyst:foundayo_라벨,_승인_일정,_의사_채택_기대가_우호적으로_확인될_경우_실적_추정치_상향_가능성",
    "catalyst:2025년_매출_확대,_높은_영업이익률,_eps_성장_지속",
    "catalyst:centessa_인수_보도가_장기_파이프라인_다변화_선택지를_제공할_가능성",
    "catalyst:923-925_회복_후_939-955_및_976-979_저항대_돌파_시_기술적_회복_신뢰도_상승"
  ]
}